Financial analysts on "Wall Street" expected that "Pfizer" and "Moderna" would make a huge profit from sales of their vaccines against the emerging corona virus.
The Morgan Stanley Foundation, which specializes in financial and investment services, estimates that Pfizer will achieve revenues of up to $ 19 billion from selling its vaccine in 2021 alone, in addition to the $ 975 million it will collect from the same source this year.
Morgan Stanley analysts also expected that Pfizer will raise 9.3 billion dollars from the sale of the Covid-19 vaccine, in consolidated profits in the next two years 2022 and 2023.
The promising results of the Corona vaccine were reflected in the shares of the companies "Pfizer" and "Biontech", as the share price of the first jumped 12 percent this year, while the shares of the second achieved a growth of about 300 percent, which prompted the market value to be set at $ 30 billion. .
On the other hand, the news about Moderna´s development of its own anti-epidemic vaccine helped raise the company´s market value to $ 62 billion, after its shares jumped 700 percent in 2020.
